Ophthalmology

1 Credit / Cardiology, Neurology

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1.5 Credits / Endocrinology, Diabetes & Metabolism, Ophthalmology/Optometry

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Ophthalmology/Optometry

Harnessing Data-Driven Insights and Innovations to Enhance AMD and DME Management: Strategic Approaches for Managed Care

1.5 Credits / Ophthalmology/Optometry

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

1.5 Credit / Ophthalmology/Optometry

Leveraging Novel Therapies to Transform Demodex Blepharitis Care (Pharmacy Technician Credit)

1.5 Credit / Ophthalmology/Optometry

Leveraging Novel Therapies to Transform Demodex Blepharitis Care

More News

November 3rd 2022

Social Determinants of Health Associated With Severe Visual Impairment

A quality improvement study found that severe visual impairment was affected by various social determinants of health, including low socioeconomic status, race, and educational level.

November 1st 2022

Dr Paul Hahn: Retina Field Has Been Rife With Therapeutic Changes

Recent FDA approvals and therapies under FDA review are adding new treatments to the armamentarium, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

October 27th 2022

Dr Michel Michaelides Speaks About Implications of Gene Therapy Study Results in Ophthalmology

Skylar Jeremias Julia Bonavitacola

The results of a study showing improved functional vision and retinal sensitivity have implications for gene therapy in ophthalmological conditions, explained Michel Michaelides, MD, FACP, a consultant ophthalmologist and a professor of ophthalmology at the University College London Institute of Ophthalmology's Genetics Department.

October 18th 2022

Dr Steven Yeh: Xipere’s New Delivery Method Requires Patient, Physician Education

Patients with uveitis and their physicians may be very familiar with intravitreal injections, but triamcinolone acetonide injectable suspension (Xipere) has a novel delivery method, said Steven Yeh, MD, professor and the Stanley Truhlsen Jr. Chair in Ophthalmology at the Truhlsen Eye Institute, University of Nebraska Medical Center.

October 11th 2022

Dr Parisa Emami-Naeni on the Lack of Racial Diversity in Ophthalmology Residency Programs

Different factors have contributed to the lack of racial diversity in ophthalmology residency programs, and these programs build the future of the workforce, said Parisa Emami-Naeni, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.

October 10th 2022

Implementing Clinical Informatics Tools for Primary Care–Based Diabetic Retinopathy Screening

Sally L. Baxter, MD, MSc Quinn Quackenbush, MSN, RN John Cerda, BA Chhavi Gregg, BDS, MHA Marlene Millen, MD Christine Thorne, MD, MPH

The authors describe a primary care–based diabetic retinopathy screening program incorporating telemedicine, strong health information technology engagement, and development of clinical informatics tools.

October 4th 2022

Dr Paul Hahn Highlights Emerging Technologies in Ophthalmology

It is an exciting time in the field of retina for emerging technologies, said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

October 3rd 2022

Family Medicine Doctors, AI Could Be Effective in DR Screening

Posters presented at AAO 2022 found that family medicine doctors and artificial intelligence (AI) were able to screen patients for diabetic retinopathy (DR) effectively, although false negatives in AI need to be improved.

September 27th 2022

Dr Paul Hahn Highlights Shifting Trends Among Retina Specialists

There has been a sea change in how retina specialists treat retinal diseases, with a progressive shift toward more utilization of anti–vascular endothelial growth factor (VEGF), said Paul Hahn, MD, vitreoretinal surgeon at NJRetina.

September 26th 2022

Telemedicine, Innovations in Ophthalmology, Inclusive Leadership Among Topics to Be Covered at AAO 2022

The American Academy of Ophthalmology (AAO) will hold its conference in person in Chicago and online from September 30 to October 3, 2022.

September 25th 2022

Students in Urban Areas More Likely to Have Myopia, Anisometropia

A study conducted in Dalian, China, found that children aged 6 to 18 years in urban areas had a higher likelihood of myopia and anisometropia compared with students in rural areas.

September 20th 2022

Teleophthalmology Reduces Rates of Vision Loss, Improves Access to Care

Teleophthalmology not only improves access to care and lowers the cost of care, but it can reduce rates of vision loss for patients with type 2 diabetes, said Parisa Emami-Naeni, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.

September 19th 2022

Black, Mexican-American Adolescents More Likely to Have Poor Visual Function

Adolescents who identified as Black, Mexican-American, or low-income and/or were not US citizens were more likely to report worse subjective visual function.

September 12th 2022

Patients Using SCS Triamcinolone Acetonide Had Lower Corticosteroid-Related IOP Elevation

A study found that patients who had no need of rescue therapy had a reduced risk of corticosteroid-related intraocular pressure (IOP) elevation when using SCS triamcinolone acetonide.

September 9th 2022

Fluorescein Angiography Predominantly Peripheral Lesions Associated With Worsening of Diabetic Retinopathy

A prospective, multicenter, longitudinal observational study found that diabetic retinopathy worsening could be associated with fluorescein angiography predominantly peripheral lesions over 4 years.

September 6th 2022

Dr Vivienne Hau: Without Representation, Clinical Trials Cannot Adequately Judge Drug Effectiveness

Different populations respond differently to drugs and treatments, but without adequate representation in clinical trials, it will be hard to judge the effectiveness of a new treatment, explained Vivienne Hau, MD, clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine.

August 30th 2022

Wearing Glasses Inversely Associated With COVID-19 in Unadjusted Analysis

A cohort study found that there was an inverse association between COVID-19 infection and wearing glasses in an unadjusted analysis, although this association was not identified when adjusting for confounders.

August 23rd 2022

Dr Vivienne Hau on the Role of Physicians, Researchers to Address Needs of Racial/Ethnic Minorities

Adequate training will help physicians and researchers better address the needs of the communities they’re targeting, explained Vivienne Hau, MD, clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine.

August 22nd 2022

Links Found Between Cataract, Asthma Development

After examining national survey data, researchers found a bidirectional association in patients with cataracts and with asthma.

August 17th 2022

Teleophthalmology Is Here Today, but Insurance Coverage, Reimbursement Will Change

Insurance reimbursement for teleophthalmology services is not consistent among populations and only recently received a boost due to flexibilities allowed during the pandemic, said Parisa Emami-Naeini, MD, MPH, assistant professor of ophthalmology at University of California, Davis, and vitreoretinal surgeon and uveitis specialist at UC Davis Eye Center.

August 10th 2022

Eye Problems Started or Worsened During Remote School for Some Children, Review Says

A systematic review found that children who engaged in remote learning during the COVID-19 pandemic had induced or exacerbated visual disturbances.

August 2nd 2022

Dr Vivienne Hau Highlights the Need for Better Trial Design for Patient Diversity

Getting a more diverse patient population in clinical trials may be as simple as including paperwork in more languages, but good training among investigators and study coordinators can help identify unconscious biases that may also have an impact, explained Vivienne Hau, MD, clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine.

July 31st 2022

Vitreoretinal Surgery Has Higher Costs in Europe, Postoperative Complications in US

Research presented at the American Society of Retina Specialists conference found that vitreoretinal surgery had cost and health implications in both Europe and the United States.

July 25th 2022

Dr Sabin Dang Discusses the Impact of Delayed Treatment in Retina Diseases

In retina surgery, obtaining prior authorization is an extra burden, and a delay in treatment for some of these patients could mean loss of vision, said Sabin Dang, MD, ophthalmologist with The Retina Institute.

July 18th 2022

Using AI to Screen for Preventable Infant Blindness in Underresourced Countries

A recent study examined whether an artificial intelligence (AI) trained risk model could screen for retinopathy of prematurity, a leading cause of preventable blindness in infants in low- and middle-income countries, via telehealth.

July 15th 2022

Ganglion Cell Complex Thinning Associated With Vision-Related Quality of Life

Faster and sectoral central location of ganglion cell complex thinning could be used to determine the risk of vision-related quality of life in patients with glaucoma.

July 11th 2022

Diabetic Retinopathy Associated With Increased Risk of Stroke

A recent review found a likely association between diabetic retinopathy and increased risk of stroke with type 1 and type 2 diabetes.

July 3rd 2022

Study Finds Association Between Migraines, Ocular Motor Cranial Nerve Palsy

A population-based, observational, retrospective cohort study found that there was an association between migraines and ocular motor cranial nerve palsy.

July 1st 2022

Aetna to Halt Prior Authorization Requirement for Cataract Surgeries

Aetna announced it they would no longer be requiring prior approval for cataract surgeries starting in July.

June 28th 2022

Chart-Based Visual Function Tests Limited in Detecting Intermediate AMD